Phase 3 Trial of Serbian Seasonal Influenza Vaccine
Clinical trial NCT02935192 · COMPLETED
Trial details
- NCT number
- NCT02935192
- Sponsor
- Institute of Virology, Vaccines and Sera, Torlak
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2017-01-08
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.